Health experts warn this flu season could be unusually severe, with early spread and concerning H3N2 strain activity across ...

California could see an early and especially sharp start to the annual flu season, as a combination of low vaccination rates ...

Merck will acquire Cidara Therapeutics in a nearly $9.2 billion deal, the companies said on Friday, gaining access to an experimental drug for flu prevention.

The mutated strain, known as subclade K, is causing a surge in cases in the United Kingdom, Canada, and Japan. Here's what to know.

But in many countries, immunisation rates were far below target levels in the last flu season, according to new data from the ...

During the second week of November, more than 3,000 Texans visited an emergency room for the flu —more than twice the number ...

(Reuters) -Merck will acquire Cidara Therapeutics in a nearly $9.2 billion deal, gaining access to an experimental flu drug in its effort to diversify ahead of patent loss for its blockbuster cancer ...

The move is in response to changes on the U.S. Centers for Disease Control's website that promotes a possible link with ...

Friendsgiving is exactly what it sounds like: A gathering close to the date of Thanksgiving, starring many of its starchy ...